You have searched for "Drug Control Authority"
Showing 1-10 of 220
KUALA LUMPUR: CGS-CIMB Equities Research is retaining its Add call for Duopharma Biotech with an unchanged target price of RM3.67 due to the potential long-term earnings prospects from the development of vaccine manufacturing capabilities, which is a key rerating catalyst.
PETALING JAYA: Malaysia’s arsenal against Covid-19 has got a boost after Sinopharm and Johnson & Johnson vaccines were granted conditional approval for use in the national immunisation programme.
PUTRAJAYA: Malaysia may purchase more doses of the Sinovac Covid-19 vaccine to cover up shortfalls caused by a possible disruption to its supply of AstraZeneca vaccines from Thailand.
PETALING JAYA: The Sinopharm and Johnson & Johnson Covid-19 vaccines have been granted conditional approval for use in the country’s National Covid-19 Immunisation Programme, says the Health Ministry.
KUCHING: Sarawak expects to receive the CanSino Covid-19 vaccine by mid-July, says Datuk Amar Douglas Uggah Embas.
KOTA BARU: The government will be supplying the CanSino vaccine to Kelantan in July to inoculate people living in the interior including Orang Asli.
PETALING JAYA: The Covid-19 Immunisation Task Force (CITF)'s move to give priority to students sitting for exams this year to get vaccinated is welcomed, says Datuk Dr Mohd Radzi Md Jidin.